Active Ingredient
Active ingredients: Adenosine 0.04%, Tranexamic acid 0.01%
The following Structured Product Label (SPL) was submitted to the FDA by Reviresco Co., Ltd. for the product Skinmd Laboratories Revitox Blue (NDC 71974-040). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, inactive ingredient, purpose, warnings, keep out of reach of children, uses, directions, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active ingredients: Adenosine 0.04%, Tranexamic acid 0.01%
Inactive ingredients: Water, Beta-Glucan, Alcohol Denat. , Hydrolyzed Hyaluronic Acid , Copper Tripeptide-1, Acetyl Hexapeptide-8 , Rhodiola Sacra Root Extract, Caprylyl Glycol, Glycerin, 1,2-Hexanediol, PEG-60 Hydrogenated Castor Oil, Methylpropanediol
Purpose: Anti wrinkle
Warnings: 1. Stop use if the following symptoms appear, continued use can worsen the situation. And please visit a doctor. - Red spot, swelling, itching generate when using it. - Above symptoms generates on applied area causing by UV. 2. Avoid applying to wound area, eczema, skin disease and so on. 3. Cautions for usage and storage - Please cover the cap after use. - Keep it out of reach of children. - Keep it store in shadow and avoid heat and cold place to store.
Keep it out of reach of children
Uses: For anti-wrinkle
Directions: 1. Clean your face carefully and remove the water remains. 2. Open the lid of the vial. 3. Put the transparent lid which can be found in the box on the solution bottle. 4. Take 2cc Revitoxblue solution on the back of your hand. 5. Smear Revitoxblue solution on the face where you want and pat the face to help absorb. 6. After using, please cover the transparent lid and store it in refrigerator. 7. Using it every morning and night.
* Please review the disclaimer below.